<Flag xmlns="http://hl7.org/fhir">
  <id value="bb-pat03-bb-aml-01"/>
  <meta>
    <profile value="http://nictiz.nl/fhir/StructureDefinition/cio-SurveillanceDecision"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <table>
        <caption>Attentievlag. Subject: Patient, Petra XXX_Drijkoningen. Id: pat03-bb-aml-01 (urn:oid:2.16.840.1.113883.2.4.3.11.999.26.1.754), Categorie: <span title="surveillance (225419007 - SNOMED CT)">surveillance</span>, Status: actief<span style="display: block;">Auteur: Healthcare professional (role), Peter van Pulver, HUISARTS, Huisartsenpraktijk Pulver &amp; Partners</span>
        </caption>
        <tbody>
          <tr>
            <th>Categorie</th>
            <td>
              <span title="surveillance (225419007 - SNOMED CT)">surveillance</span>
            </td>
          </tr>
          <tr>
            <th>Code</th>
            <td>
              <span title="AMLODIPINE (62081 - G-Standaard Bestand 750)">AMLODIPINE</span>
            </td>
          </tr>
          <tr>
            <th>Detail</th>
            <td>Reactie, NORVASC TABLET 5MG, diagnosedatum: T-8Y{13:08:15}</td>
          </tr>
          <tr>
            <th>Periode</th>
            <td>Vanaf ${DATE, T, Y, -8}T13:08:15+02:00</td>
          </tr>
        </tbody>
      </table>
    </div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/flag-detail">
    <valueReference>
      <reference value="AllergyIntolerance/reac-pat03-rea-aml-01"/>
      <type value="AllergyIntolerance"/>
      <display value="Reactie, NORVASC TABLET 5MG, diagnosedatum: T-8Y{13:08:15}"/>
    </valueReference>
  </extension>
  <extension url="http://nictiz.nl/fhir/StructureDefinition/ext-Comment">
    <valueString value="invaliderende bijwerking bij amlodipine tablet gebruik i.h.k.v. angina pectoris "/>
  </extension>
  <extension url="http://nictiz.nl/fhir/StructureDefinition/ext-MedicationHypersensitivity.Identifier">
    <valueIdentifier>
      <system value="urn:oid:2.16.840.1.113883.2.4.3.11.999.26.1.341"/>
      <value value="pat03-gmo-02"/>
    </valueIdentifier>
  </extension>
  <identifier>
    <system value="urn:oid:2.16.840.1.113883.2.4.3.11.999.26.1.754"/>
    <value value="pat03-bb-aml-01"/>
  </identifier>
  <status value="active"/>
  <category>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="225419007"/>
      <display value="surveillance"/>
    </coding>
  </category>
  <code>
    <coding>
      <system value="urn:oid:2.16.840.1.113883.2.4.4.1.750"/>
      <code value="62081"/>
      <display value="AMLODIPINE"/>
    </coding>
    <text value="Monitor the use of AMLODIPINE as treatment for the patient, since this substance is unsafe for the patient."/>
  </code>
  <subject>
    <reference value="Patient/patient-XXX-Drijkoningen"/>
    <type value="Patient"/>
    <display value="Patient, Petra XXX_Drijkoningen"/>
  </subject>
  <period>
    <start value="${DATE, T, Y, -8}T13:08:15+02:00"/>
  </period>
  <author>
    <reference value="PractitionerRole/pracrole-000003332"/>
    <type value="PractitionerRole"/>
    <display value="Healthcare professional (role), Peter van Pulver, HUISARTS, Huisartsenpraktijk Pulver &amp; Partners"/>
  </author>
</Flag>
